Interesting facts
              Interesting Facts about 1-[2-(3,4-Dimethoxyphenyl)ethylamino]-3-(3-methylphenoxy)propan-2-ol
This compound is a notable member of the class of amines, which are characterized by the presence of one or more amine groups. It showcases fascinating characteristics and potential applications in various fields. Here are some compelling insights:
- Pharmaceutical Potential: Many compounds that contain amine groups, like this one, are often investigated for their therapeutic effects. They can act as intermediates in developing drugs for various conditions, particularly those related to neurotransmitter activity.
 - Structural Complexity: The molecular structure includes multiple aromatic rings and functional groups, which can greatly influence its pharmacokinetic properties. Understanding this complexity is vital for predicting how the compound will behave in biological systems.
 - Chiral Centers: This compound features chiral centers, making it a candidate for stereochemical studies. The different enantiomers (mirror images) of a chiral compound can exhibit different biological activities, which is crucial in drug design.
 - Research Applications: Such compounds can serve as probes in studying biochemical pathways. They can help in the elucidation of mechanisms in neurotransmission due to the involvement of phenyl and methoxy functional groups.
 - Historical Context: Compounds of this nature have been developed over the years, with researchers often modifying their structures to improve efficacy and reduce side effects. This compound exemplifies the ongoing quest for improved pharmacological agents.
 
In summary, the study of 1-[2-(3,4-dimethoxyphenyl)ethylamino]-3-(3-methylphenoxy)propan-2-ol goes beyond just its chemical structure; it taps into a broader narrative of medicinal chemistry and drug development. As the field continues to evolve, compounds like this will likely play a key role in the next generation of treatments.
Synonyms
          Bevantolol
          59170-23-9
          Bevantololum
          Bevantololum [INN-Latin]
          Bevantolol [INN:BAN]
          1-(3,4-Dimethoxyphenethylamino)-3-(m-tolyloxy)-2-propanol
          (+-)-bevantolol
          UNII-34ZXW6ZV21
          1-((2-(3,4-Dimethoxyphenyl)ethyl)amino)-3-(3-methylphenoxy)-2-propanol
          NSC-132348
          BRN 2769444
          34ZXW6ZV21
          1-[2-(3,4-dimethoxyphenyl)ethylamino]-3-(3-methylphenoxy)propan-2-ol
          CHEBI:238698
          BEVANTOLOL [MI]
          BEVANTOLOL [INN]
          BEVANTOLOL [WHO-DD]
          1-(3,4-dimethoxyphenethylamino)-3-m-tolyloxy-propan-2-ol
          DTXSID70860597
          1-[2-(3,4-Dimethoxy-phenyl)-ethylamino]-3-m-tolyloxy-propan-2-ol
          1-{[2-(3,4-dimethoxyphenyl)ethyl]amino}-3-(3-methylphenoxy)propan-2-ol
          NSC 132348
          Bevantololum (INN-Latin)
          2-Propanol, 1-((2-(3,4-dimethoxyphenyl)ethyl)amino)-3-(3-methylphenoxy)-
          (+/-)-1-((3,4-DIMETHOXYPHENETHYL)AMINO)-3-(M-TOLYLOXY)-2-PROPANOL
          2-PROPANOL, 1-((2-(3,4-DIMETHOXYPHENYL)ETHYL)AMINO)-3-(3-METHYLPHENOXY)-, (+/-)-
          1-((3,4-Dimethoxyphenethyl)amino)-3-(m-tolyloxy)propan-2-ol
          (+/-)-Bevantolol; DL-Bevantolol; NSC 132348
          1-(2-(3,4-Dimethoxy-phenyl)-ethylamino)-3-m-tolyloxy-propan-2-ol
          1-((2-(3,4-dimethoxyphenyl)ethyl)amino)-3-(3-methylphenoxy)propan-2-ol
          (+/-)-bevantolol
          SCHEMBL49721
          MLS003876814
          CHEMBL314010
          C07AB06
          DTXCID80197265
          HXLAFSUPPDYFEO-UHFFFAOYSA-N
          HMS3604B08
          HY-A0249
          NSC132348
          AKOS016014301
          DB01295
          SMR002529477
          ()-Bevantolol; DL-Bevantolol; NSC 132348
          EN300-741859
          SBI-0653887.0001
          L013370
          Q1956953
          BRD-A18233884-003-02-7
          Z31382955
          1-[[2-(3,4-dimethoxyphenyl) ethyl]amino]-3-(3-methyl-phenoxy)-2-propanol
              
Solubility of 1-[2-(3,4-dimethoxyphenyl)ethylamino]-3-(3-methylphenoxy)propan-2-ol
The solubility of the compound designated as 1-[2-(3,4-dimethoxyphenyl)ethylamino]-3-(3-methylphenoxy)propan-2-ol (C15H25NO3) can be characterized by several factors related to its molecular structure.
Factors Influencing Solubility
As a general insight, compounds with significant hydrophobic regions can demonstrate lower solubility in water, while those with multiple polar functional groups are often more soluble in aqueous solutions. For 1-[2-(3,4-dimethoxyphenyl)ethylamino]-3-(3-methylphenoxy)propan-2-ol, solubility can be maximized in environments where the solvent's polarity aligns with the polar characteristics of the molecule.
It is essential to consider the overall environment as many drugs and compounds behave differently when salts or alterations in their chemical structure are introduced.